| Sources | Names Used |
|---|---|
| CTRPv2 | Compound 23 citrate |
| PharmacoGx | Compound 23 citrate |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LMNB1 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-08 |
| mRNA | WAS | CTRPv2 | pan-cancer | AAC | 0.2 | 0.001 |
| mRNA | MDM4 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-07 |
| mRNA | DOT1L | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-06 |
| mRNA | FAM83F | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | TFAP4 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-08 |
| mRNA | ICA1 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | ARHGAP45 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-06 |
| mRNA | FBRSL1 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
| mRNA | RNF44 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-11 |
